Market By Product, Test Type, Technology And Geography | Forecast 2019-2027
As per Triton Market Research, the newborn screening market in the Middle East and Africa is expected to upsurge with 13.49% of CAGR in the forecast duration between 2019 and 2027.
The report on the Middle East and Africa’s newborn screening market includes the following countries:
• United Arab Emirates
• Turkey
• Saudi Arabia
• South Africa
• Rest of the Middle East & Africa
Report scope can be customized per your requirements. Request For Customization
The Middle East and Africa newborn screening market is mainly driven by supportive government norms and policies along with the increasing adoption of newborn screening in South Africa. According to North-West University (South Africa), around 1 million total births take place every year. The predicted incidence of NBS conditions accounts for a 1:2000 infant ratio. The total newborns screened per year accounts for 4000, which is 0.4% of all the births screened in South Africa, and around 2000 babies are saved through newborn screening per year in the country. According to the Department of Health of the United Arab Emirates, the Newborn Screening Program, which has been framed by the central government of the country, ensures that every newborn baby in the country should have access to the comprehensive Newborn Screening Programme.
The programme mainly includes parent education, screening tests, comprehensive newborn physical exam, counseling, follow-up, diagnosis, treatment and evaluation. Under this programme, every newborn would be screened for specific hereditary and congenital disorders, which are negatively impactful or potentially fatal or are not apparent at birth. The most common disorders that occur in the UAE considering newborn babies mainly include hearing loss, phenylketonuria, congenital hypothyroidism, sickle cell anemia, galactosemia, hyperplasia and cystic fibrosis, which is further paving the adoption and growth of the newborn screening market in the Middle East and Africa region.
According to the WHO, more than 7,178 infants’ deaths occur daily worldwide. Most of the deaths of these infants can be prevented during and after birth, especially during the first week of life with health measures and care. To overcome such a situation, newborn screening is a new opportunity in developing regions. The increasing birth rate and preterm birth rate in developing countries are subsequently creating significant demand for diagnosis. This, in turn, is likely to create lucrative growth opportunities for the newborn screening market.
The notable players in the market are GE Healthcare, Limited, ZenTech S.A., Bio-Rad Laboratories, Inc., Trivitron Healthcare, Natus Medical, Incorporated, Agilent Technologies, Inc., Medtronic Plc, Cardinal Health, Inc., Thermo Fisher Scientific, Inc., BioTek Instruments, Inc., PerkinElmer, Inc., NeoGen Labs Pvt. Ltd., SCIEX, Waters Corporation and Masimo Corporation.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA NEWBORN SCREENING MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. KEY
INSIGHTS
2.2.1. DEMAND
FOR NEWBORN SCREENING INSTRUMENTS IS RISING STEADILY
2.2.2. GROWTH
IN DRY BLOOD SPOT TEST
2.2.3. TECHNIQUES
USED IN NEWBORN SCREENING TESTS
2.3. EVOLUTION
& TRANSITION OF NEWBORN SCREENING
2.4. PORTER’S
FIVE FORCE ANALYSIS
2.4.1. THREAT
OF NEW ENTRANTS
2.4.2. THREAT
OF SUBSTITUTE
2.4.3. BARGAINING
POWER OF SUPPLIERS
2.4.4. BARGAINING
POWER OF BUYERS
2.4.5. THREAT
OF COMPETITIVE RIVALRY
2.5. KEY
IMPACT ANALYSIS
2.5.1. RELIABILITY
2.5.2. COST
2.5.3. AVAILABILITY
2.5.4. TECHNOLOGICAL
ADVANCEMENT
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. VENDOR
SCORECARD
2.8. INDUSTRY
COMPONENTS
2.8.1. RAW
MATERIAL SUPPLIERS
2.8.2. MANUFACTURERS
2.8.3. DISTRIBUTORS
2.8.4. END-USERS
2.9. REGULATORY
FRAMEWORK
2.10. INDUSTRY
PLAYER POSITIONING
2.11. KEY
MARKET STRATEGIES
2.11.1. PRODUCT
LAUNCH
2.12. MARKET
DRIVERS
2.12.1. INCREASE
IN OCCURRENCES OF NEWBORN DISEASES
2.12.2. GROWING
NUMBER OF INFANTS WITH BIRTH DEFECT
2.12.3. BACKING
OF GOVERNMENT TOWARDS NEWBORN CHILD HEALTH
2.12.4. RISING
AWARENESS FOR PEDIATRIC CONGENITAL HEART DISEASE
2.13. MARKET
RESTRAINTS
2.13.1. SOCIO-ECONOMIC
HURDLES IN THE IMPLEMENTATION OF NEWBORN CHILD SCREENING
2.14. MARKET
OPPORTUNITIES
2.14.1. NEWBORN
SCREENING HELPS IN EARLY IDENTIFICATION AND MANAGEMENT OF AFFECTED NEWBORNS
2.14.2. TECHNOLOGICAL
ADVANCEMENTS IN NEWBORN SCREENING
2.14.3. INCREASE
IN NUMBER OF PREGNANT WOMEN WITH ADVANCED MATERNAL AGE
2.15. MARKET
CHALLENGES
2.15.1. DEARTH
OF SKILLED PROFESSIONAL IN HEALTHCARE INDUSTRY
2.15.2. MAINTENANCE
OF EQUIPMENT IN HOSPITAL
3. NEWBORN
SCREENING MARKET OUTLOOK - BY PRODUCT
3.1. NEWBORN
SCREENING INSTRUMENTS
3.2. NEWBORN
SCREENING REAGENTS & ASSAY KITS
4. NEWBORN
SCREENING MARKET OUTLOOK - BY TEST TYPE
4.1. HEARING
SCREEN TEST
4.2. CRITICAL
CONGENITAL HEART DISEASE (CCHD) TEST
4.3. DRY
BLOOD SPOT TEST
5. NEWBORN
SCREENING MARKET OUTLOOK - BY TECHNOLOGY
5.1. TANDEM
MASS SPECTROMETRY
5.2. PULSE
OXIMETRY
5.3. ENZYME-BASED
ASSAYS
5.4. DNA-BASED
ASSAYS
5.5. ELECTROPHORESIS
5.6. OTHERS
6. NEWBORN
SCREENING MARKET - REGIONAL OUTLOOK
6.1. UNITED
ARAB EMIRATES
6.2. TURKEY
6.3. SAUDI
ARABIA
6.4. SOUTH
AFRICA
6.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. SCIEX
7.2. BIOTEK
INSTRUMENTS, INC.
7.3. BIO-RAD
LABORATORIES, INC.
7.4. CARDINAL
HEALTH, INC.
7.5. GE
HEALTHCARE, LIMITED
7.6. AGILENT
TECHNOLOGIES, INC.
7.7. MASIMO
CORPORATION
7.8. NATUS
MEDICAL, INCORPORATED
7.9. MEDTRONIC
PLC
7.10. THERMO
FISHER SCIENTIFIC, INC.
7.11. NEOGEN
LABS PVT. LTD.
7.12. PERKINELMER,
INC.
7.13. ZENTECH
S.A.
7.14. WATERS
CORPORATION
7.15. TRIVITRON
HEALTHCARE
8. METHODOLOGY
& SCOPE
8.1. RESEARCH
SCOPE
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
TABLE 2: MARKET
ATTRACTIVENESS INDEX
TABLE 3: VENDOR
SCORECARD
TABLE 4: REGULATORY
FRAMEWORK
TABLE 5: LIST OF
PRODUCT LAUNCHES
TABLE 6: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY PRODUCT, 2019-2027 (IN $ MILLION)
TABLE 7: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2019-2027 (IN $ MILLION)
TABLE 8: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2019-2027 (IN $ MILLION)
TABLE 9: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY COUNTRY, 2019-2027 (IN $ MILLION)
FIGURE 1: PORTER’S FIVE
FORCE ANALYSIS
FIGURE 2: KEY BUYING
IMPACT ANALYSIS
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: INDUSTRY
PLAYER POSITIONING IN 2018 (IN %)
FIGURE 5: FERTILITY
RATE (AVERAGE BIRTHS PER WOMAN IN %) IN 2017
FIGURE 6: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY NEWBORN SCREENING INSTRUMENTS,
2019-2027 (IN $ MILLION)
FIGURE 7: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY NEWBORN SCREENING REAGENTS & ASSAY
KITS, 2019-2027 (IN $ MILLION)
FIGURE 8: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY HEARING SCREEN TEST, 2019-2027 (IN $
MILLION)
FIGURE 9: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY CRITICAL CONGENITAL HEART DISEASE
(CCHD) TEST, 2019-2027 (IN $ MILLION)
FIGURE 10: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY DRY BLOOD SPOT TEST, 2019-2027 (IN $
MILLION)
FIGURE 11: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY TANDEM MASS SPECTROMETRY, 2019-2027 (IN
$ MILLION)
FIGURE 12: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY PULSE OXIMETRY, 2019-2027 (IN $
MILLION)
FIGURE 13: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY ENZYME BASED ASSAY, 2019-2027 (IN $
MILLION)
FIGURE 14: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY DNA BASED ASSAYS, 2019-2027 (IN $ MILLION)
FIGURE 15: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY ELECTROPHORESIS, 2019-2027 (IN $
MILLION)
FIGURE 16: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, BY OTHERS, 2019-2027 (IN $ MILLION)
FIGURE 17: MIDDLE EAST
AND AFRICA NEWBORN SCREENING MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)
FIGURE 18: UNITED ARAB
EMIRATES NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 19: TURKEY
NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 20: SAUDI ARABIA
NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 21: SOUTH AFRICA
NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 22: REST OF
MIDDLE EAST & AFRICA NEWBORN SCREENING MARKET, 2019-2027 (IN $ MILLION)